StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on FGEN. William Blair restated a “market perform” rating on shares of FibroGen in […]
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on FGEN. William Blair restated a “market perform” rating on shares of FibroGen in […]
